winph99. com Bitcoin is tantalizing investors with a strong advance that's bringing its value close to $100,000 per coin. While buying into the cryptocurrency can mean strapping in for a volatile ride, one bullish hedge fund manager sees continued momentum if bitcoin can hit six figures. As of Wednesday afternoon, the price of bitcoin sits around $98,740. The iShares Bitcoin Trust ETF ( ) jumped roughly 3.8% to 56.53 in the stock market today. It's just shy of its Nov. 22 high of 56.86. Bitcoin's value is up more than 115% since the start of 2024. The asset's most dramatic rise came following the U.S. election in November, with Donald Trump's victory raising expectations of a crypto-friendly administration and pullback in regulation. The cryptocurrency has surged about 40% from the election until now. Its value could go even higher — with a surge of momentum once bitcoin passes the $100,000 mark, according to a crypto hedge fund manager. "When a stock breaks a major round number, it not only hits it, it runs way past," Roppel Report founder Jim Roppel told Investor's Business Daily's "Monthly Market Report." Roppel says momentum behind bitcoin will continue, boosted by press coverage of the cryptocurrency's milestone and the stock market's risk-on mentality. Bitcoin's Run Boosted By Trump Bitcoin bottomed in early August, shortly after then-candidate Donald Trump appeared at the Bitcoin 2024 conference in Nashville, Tenn., in late July. Trump has called for a strategic reserve of cryptocurrency held by the government. Momentum in bitcoin continued after Trump's election, with crypto-leveraged ( ) buying an additional 15,400 bitcoins, worth $1.5 billion, in late November. While the company nominally specializes in data analytics and security software, its corporate strategy of converting stock sales to bitcoin makes it the largest corporate holder of the cryptocurrency and a rough proxy for bitcoin's value. "Initially, people thought he might be absolutely crazy, and now he looks kind of more like a genius," said Roppel, referring to MicroStrategy Executive Chairman Michael Saylor. "If bitcoin goes higher, MicroStrategy is going to go significantly higher." Even with his bullish outlook, Roppel cautioned investors about managing risk at current levels. Chasing an extended move, especially in something that has a volatile nature, can lead to investors getting burned. Tesla And Gold Other perceived winners of a bitcoin boom include ( ), led by crypto proponent Elon Musk. The EV company has made its cars available for purchase in select cryptocurrencies in the past, including bitcoin and dogecoin. Musk himself is set to join the Trump administration in an advisory role as co-head of the Department of Government Efficiency. The bullish move in crypto has come at a time when gold has pulled back, with Roppel seeing the traditional safe-haven asset losing prominence. "Bitcoin is a better gold, and the market agrees," he said. Fed chair Jerome Powell, meanwhile, while speaking at the New York Times DealBook Summit on Wednesday.

US sex-abuse watchdog fires investigator after learning of his arrest for stealing drug money DENVER (AP) — The U.S. Center for SafeSport abruptly fired one of its investigators last month after learning he’d been arrested for stealing money confiscated after a drug bust he was part of during his previous job as a police officer. Jason Krasley left his job with the Allentown Police Department in Pennsylvania in 2021 and was hired by the Denver-based SafeSport center to look into sensitive cases involving sex abuse and harassment. The center said it conducts multiple interviews and a “comprehensive background check” of potential employees. The center said it was looking into cases Krasley handled to make sure they were dealt with appropriately. Jim Larrañaga steps down at Miami, Bill Courtney takes over to finish season CORAL GABLES, Fla. (AP) — Jim Larrañaga has stepped down as Miami’s men’s basketball coach effective immediately. Larrañaga will be replaced by associate head coach Bill Courtney — one of Larrañaga’s best friends for the past three decades or so — for the remainder of the season. The now-former coach says he loves the university but believes it's the right time to step away. Larrañaga says "I’ve tried every which way to keep this going.” Larrañaga joins a long line of prominent college basketball coaches who have left their jobs in recent years citing the changes in the game and the challenge of coaching in the Name, Image and Likeness era. Detroit Red Wings fire coach Derek Lalonde, name Todd McLellan as his replacement The Detroit Red Wings have fired coach Derek Lalonde and named Todd McLellan as his replacement. The move a day after Christmas comes after the Red Wings lost 21 of their first 34 games this season. They're on a three-game skid. Assistant Bob Boughner was also fired and Trent Yawney hired to work on McLellan's staff. McLellan signed a multiyear contract to start his fourth NHL head coaching job. Lalonde was nearly midway through his third season with Detroit after winning the Stanley Cup twice as an assistant with Tampa Bay. Penn State offensive coordinator Kotelnicki's creativity has the Nittany Lions humming in the CFP Penn State's offense is thriving under first-year offensive coordinator Andy Kotelnicki. The Nittany Lions are one of a handful of Power Four schools averaging 200 yards per game rushing and receiving heading into their College Football Playoff quarterfinal against Boise State. Penn State has one of the most unique offensive weapons in the country in tight end Tyler Warren. Warren has 92 receptions this season and has become a threat out of the backfield, rushing for 197 yards and two touchdowns. Pat Riley says the Miami Heat will not trade Jimmy Butler ORLANDO, Fla. (AP) — If Jimmy Butler wants a trade, the Miami Heat have no plans to make him happy. Heat President Pat Riley — in a rare move — spoke out to address rumors Thursday, saying the team has no plans to trade Butler. It’s a clear sign that, if necessary, the team will be willing to let Butler leave as a free agent and get nothing in return. Riley says in a release distributed by the team "we usually don’t comment on rumors, but all this speculation has become a distraction to the team and is not fair to the players and coaches.” Organizers say two sailors have died in Sydney to Hobart yacht race amid wild weather conditions SYDNEY (AP) — Organizers said that two Sydney to Hobart sailors have died at sea amid wild weather conditions that forced line honors favorite Master Lock Comanche to withdraw among mass retirements. The Cruising Yacht Club of Australia, which administers the yacht race, has said that one sailor each on entrants Flying Fish Arctos and Bowline were killed after being struck by the boom, a large horizontal pole at the bottom of the sail. The race will continue as the fleet continues its passage to Constitution Dock in Hobart, with the first boats expected to arrive later on Friday or early Saturday morning. Haaland penalty failure and Fernandes red card pile on woes for City and United in Premier League Erling Haaland’s failure from the penalty spot and Bruno Fernandes’ latest red card have compounded the woes of Manchester City and Manchester United on another tough day for the two Premier League giants. City dropped more points in its improbably poor run of form by drawing 1-1 at home to Everton. Haaland had a spot kick saved by England goalkeeper Jordan Pickford in the 53rd minute. The four-time defending champions have only won one of its last 13 games in all competitions. While City is languishing in seventh place, United is even further adrift in 14th place after a 2-0 loss at lowly Wolverhampton. Fernandes was sent off in the 47th. Simona Halep withdraws from Australian Open qualifying because of knee and shoulder pain MELBOURNE, Australia (AP) — Two-time Grand Slam champion Simona Halep has pulled out of Australian Open qualifying and a tuneup tournament in Auckland, New Zealand, because of pain in her knee and shoulder. Thursday's news represents the latest interruption of her comeback from a drug suspension. Halep posted on social media that she was feeling poorly after participating in an exhibition event in Abu Dhabi. The 33-year-old Romanian said she is planning to next enter the Transylvania Open in her home country, where play begins Feb. 3. Halep was granted a wild-card entry for qualifying in the Australian Open last week. Mahomes throws 3 TDs as Chiefs clinch AFC's top seed by breezing past the skidding Steelers 29-10 PITTSBURGH (AP) — Patrick Mahomes passed for 320 yards and three touchdowns and the Kansas City Chiefs locked up the top seed in the AFC for the fourth time in seven seasons with a 29-10 win over the Pittsburgh Steelers. The two-time defending Super Bowl champions raced to an early 13-point lead and were never really threatened by the Steelers (10-6). Pittsburgh has dropped three straight to see its chances of capturing the AFC North take another hit. Travis Kelce caught eight passes for 84 yards and a touchdown. Kelce also became the third tight end in NFL history to reach 1,000 receptions, joining Tony Gonzalez and Jason Witten. Jackson breaks Vick's NFL rushing record for QBs in Ravens' rout over Texans HOUSTON (AP) — Baltimore’s Lamar Jackson passed Michael Vick for the most yards rushing by a quarterback in NFL history in a 31-2 win over the Houston Texans in Wednesday. Jackson moved past Vick on a 6-yard run in the third quarter. Jackson had 87 yards rushing to give him 6,110 yards, moving him past Vick, who piled up 6,109 in his 13-year career.Arizona State dominates in Texas, giving CFP-seeking Big 12 exactly what it needs

6 members of dreaded gang held in Palamu

NASSAU, Bahamas -- Justin Thomas was long off the tee and made a few long putts on the back nine to overtake Scottie Scheffler with a 6-under 66 and build a one-shot lead Saturday over golf's best player going into the final round of the Hero World Challenge. Thomas is trying out a 46-inch driver — a little more than an inch longer than normal — that he previously used for practice at home to gain speed and length. He blasted a 361-yard drive to 8 feet on the par-4 seventh hole and led the field in driving distance. But it was a few long putts that put him ahead of Scheffler, who had a 69. Thomas was on the verge of falling two shots behind when he made an 18-foot par putt on the par-3 12th hole. On the reachable par-4 14th, he was in a nasty spot in a sandy area and could only splash it out to nearly 50 feet. He made that one for a most unlikely birdie, while behind him Scheffler muffed a chip on the 13th hole and made his lone bogey of a windy day. Scheffler never caught up to him, missing birdie chances on the reachable 14th and the par-5 15th. Thomas hit his approach to 3 feet for birdie on the 16th after a 343-yard drive. Scheffler made an 18-foot birdie putt on the 16th to close within one. Scheffler missed birdie chances on the last two holes from the 10-foot and 15-foot range, while Thomas missed an 8-foot birdie attempt at the last. “I had a stretch at 13, 14, 15 where I felt like I lost a shot or two there, but outside of that I did a lot of really good things today,” Scheffler said. Thomas hasn't won since the 2022 PGA Championship at Southern Hills, and a victory at Albany Golf Club wouldn't count as an official win. But the two-time major champion has made steady progress toward getting his game back in order. “I'm driving it great. I've had a lot of confidence with it,” Thomas said of his longer driver. “I feel like I've been able to put myself in some pretty good spots going into the green. I’m still not taking advantage of some of them as much as I would like, but that’s golf and we're always going to say that.” Thomas was at 17-under 199 and will be in the final group Sunday with Scheffler, who is trying to end his spectacular season with a ninth title. Tom Kim put himself in the mix, which he might not have imagined Thursday when he was 3 over through six holes of the holiday tournament. Kim got back in the game with a 65 on Friday, and then followed with 12 birdies for a 62. He had a shot at the course record — Rickie Fowler shot 61 in the final round when he won at Albany in 2017 — until Kim found a bunker and took two shots to reach the green in making a double bogey on the par-3 17th. Even so, he was only two shots behind. Ryder Cup captain Keegan Bradley (68) was four back. “Feel like I’ve been seeing signs of improvement, which is what you want and that’s all I can do,” Thomas said. “I can’t control everybody else or what’s going on, I’ve just got to keep playing as good as I possibly can and hope that it’s enough come Sunday.” ___ AP golf: https://apnews.com/hub/golfBitcoin is tantalizing investors with a strong advance that's bringing its value close to $100,000 per coin. While buying into the cryptocurrency can mean strapping in for a volatile ride, one bullish hedge fund manager sees continued momentum if bitcoin can hit six figures. As of Wednesday afternoon, the price of bitcoin sits around $98,740. The iShares Bitcoin Trust ETF ( ) jumped roughly 3.8% to 56.53 in the stock market today. It's just shy of its Nov. 22 high of 56.86. Bitcoin's value is up more than 115% since the start of 2024. The asset's most dramatic rise came following the U.S. election in November, with Donald Trump's victory raising expectations of a crypto-friendly administration and pullback in regulation. The cryptocurrency has surged about 40% from the election until now. Its value could go even higher — with a surge of momentum once bitcoin passes the $100,000 mark, according to a crypto hedge fund manager. "When a stock breaks a major round number, it not only hits it, it runs way past," Roppel Report founder Jim Roppel told Investor's Business Daily's "Monthly Market Report." Roppel says momentum behind bitcoin will continue, boosted by press coverage of the cryptocurrency's milestone and the stock market's risk-on mentality. Bitcoin's Run Boosted By Trump Bitcoin bottomed in early August, shortly after then-candidate Donald Trump appeared at the Bitcoin 2024 conference in Nashville, Tenn., in late July. Trump has called for a strategic reserve of cryptocurrency held by the government. Momentum in bitcoin continued after Trump's election, with crypto-leveraged ( ) buying an additional 15,400 bitcoins, worth $1.5 billion, in late November. While the company nominally specializes in data analytics and security software, its corporate strategy of converting stock sales to bitcoin makes it the largest corporate holder of the cryptocurrency and a rough proxy for bitcoin's value. "Initially, people thought he might be absolutely crazy, and now he looks kind of more like a genius," said Roppel, referring to MicroStrategy Executive Chairman Michael Saylor. "If bitcoin goes higher, MicroStrategy is going to go significantly higher." Even with his bullish outlook, Roppel cautioned investors about managing risk at current levels. Chasing an extended move, especially in something that has a volatile nature, can lead to investors getting burned. Tesla And Gold Other perceived winners of a bitcoin boom include ( ), led by crypto proponent Elon Musk. The EV company has made its cars available for purchase in select cryptocurrencies in the past, including bitcoin and dogecoin. Musk himself is set to join the Trump administration in an advisory role as co-head of the Department of Government Efficiency. The bullish move in crypto has come at a time when gold has pulled back, with Roppel seeing the traditional safe-haven asset losing prominence. "Bitcoin is a better gold, and the market agrees," he said. Fed chair Jerome Powell, meanwhile, while speaking at the New York Times DealBook Summit on Wednesday.

Israel strikes Houthi rebels in Yemen's capital while the WHO chief says he was meters away JERUSALEM (AP) — A new round of Israeli airstrikes in Yemen have targeted the Houthi rebel-held capital of Sanaa and multiple ports. The World Health Organization’s director-general said the bombardment on Thursday took place just “meters away” as he was about to board a flight in Sanaa. He says a crew member was hurt. The strikes followed several days of Houthi attacks and launches setting off sirens in Israel. Israel's military says it attacked infrastructure used by the Houthis at the international airport in Sanaa, power stations and ports. The Israeli military didn't immediate respond to questions about the WHO chief's statement. Trump has pressed for voting changes. GOP majorities in Congress will try to make that happen ATLANTA (AP) — Republicans in Congress plan to move quickly in their effort to overhaul the nation’s voting procedures, seeing an opportunity with control of the White House and both chambers of Congress. They want to push through long-sought changes such as voter ID and proof-of-citizenship requirements. They say the measures are needed to restore public confidence in elections. That's after an erosion of trust that Democrats note has been fueled by false claims from Donald Trump and his allies of widespread fraud in the 2020 election. Democrats say they are willing to work with the GOP but want any changes to make it easier, not harder, to vote. Americans are exhausted by political news. TV ratings and a new AP-NORC poll show they're tuning out NEW YORK (AP) — A lot of Americans, after an intense presidential election campaign, are looking for a break in political news. That's evident in cable television news ratings and a poll from The Associated Press-NORC Center for Public Affairs Research. The poll found nearly two-thirds of Americans saying they've found the need recently to cut down on their consumption of political and government news. That's particularly true among Democrats following President-elect Donald Trump's victory, although a significant number of Republicans and independents feel the same way. Cable networks MSNBC and CNN are really seeing a slump. That's also happened in years past for networks that particularly appeal to supporters of one candidate. Israel's plan to double the number of settlers in the Golan Heights is met with conflicting emotions EIN ZIVAN, Golan Heights (AP) — Earlier this month, Syrian leader Bashar Assad was ousted after nearly 25 years in power. Within hours, Israeli tanks rolled into the Golan Heights' demilitarized buffer zone in Syria created as part of a 1974 ceasefire between the countries. Days later, the Israeli government approved a plan to double the population of settlers in the Golan Heights. Israel seized the mountainous region from Syria in 1967, and most of the world considers it occupied Syrian territory. In the towns and kibbutzim of Israeli-controlled Golan, the news has been met with a mixture of skepticism, excitement and shock. Previous attempts to encourage more settlement in the Golan have received a lukewarm response. How the stock market defied expectations again this year, by the numbers NEW YORK (AP) — What a wonderful year 2024 has been for investors. U.S. stocks ripped higher and carried the S&P 500 to records as the economy kept growing and the Federal Reserve began cutting interest rates. The benchmark index posted its first back-to-back annual gains of more than 20% since 1998. The year featured many familiar winners, such as Big Tech, which got even bigger as their stock prices kept growing. But it wasn’t just Apple, Nvidia and the like. Bitcoin and gold surged and “Roaring Kitty” reappeared to briefly reignite the meme stock craze. 6,000 inmates escape from a high-security prison in Mozambique amid post-election violence MAPUTO, Mozambique. (AP) — Mozambique’s police chief has said that at least 6,000 inmates have escaped from a high-security prison in the capital on Christmas Day after a rebellion, as widespread post-election riots and violence continue to engulf the country. The police chief Bernardino Rafael said 33 prisoners died and 15 others were injured during a confrontation with the security forces. The escape from the Maputo Central Prison, located 14 km southwest of the capital, started around midday Wednesday after “agitation” by a “group of subversive protesters” nearby, Rafael said, adding that prisoners at the facility snatched weapons from prison warders and started freeing other detainees. Holiday shoppers increased spending by 3.8% despite higher prices New data shows holiday sales rose this year even as Americans wrestled with still high prices in many grocery necessities and other financial worries. According to Mastercard SpendingPulse, holiday sales from the beginning of November through Christmas Eve climbed 3.8%, a faster pace than the 3.1% increase from a year earlier. The measure tracks all kinds of payments including cash and debit cards. This year, retailers were even more under the gun to get shoppers in to buy early and in bulk since there were five fewer days between Thanksgiving and Christmas. Mastercard SpendingPulse says the last five days of the season accounted for 10% of the spending. Sales of clothing, electronics and Jewelry rose. Pope brings Holy Year and prayers for better future to Rome prison, a 'cathedral of pain and hope' ROME (AP) — Pope Francis is bringing his Holy Year to Rome’s main prison. Francis traveled to Rebibbia prison Thursday on a frigid morning. He knocked on the door to the chapel and walked across the threshold. It was reenacting the gesture he performed at St. Peter’s Basilica two nights earlier on Christmas Eve. The opening of the Basilica's Holy Door officially kicked off the Jubilee year. It's a church tradition dating to 1300 that nowadays occurs every 25 years and involves the faithful coming to Rome on pilgrimages. About 32 million people are expected in Rome in 2025. India's former prime minister Manmohan Singh, architect of economic reforms, dies aged 92 NEW DELHI (AP) — India’s former Prime Minister Manmohan Singh, widely regarded as the architect of India’s economic reform program and a landmark nuclear deal with the United States, has died. He was 92. The hospital said Singh was admitted to New Delhi’s All India Institute of Medical Sciences late Thursday after his health deteriorated due to “sudden loss of consciousness at home.". He was “being treated for age-related medical conditions,” the statement added. A mild-mannered technocrat, Singh became one of India’s longest-serving prime ministers for 10 years and earned a reputation as a man of great personal integrity. But his sterling image was tainted by allegations of corruption against his ministers. Why this Mexican American woman played a vital role in the US sacramental peyote trade MIRANDO CITY, Texas (AP) — Amada Cardenas, a Mexican American woman who lived in the tiny border town of Mirando City in South Texas, played an important role in the history of the peyote trade. She and her husband were the first federally licensed peyote dealers who harvested and sold the sacramental plant to followers of the Native American Church in the 1930s. After her husband's death in 1967, Cardenas continued to welcome generations of Native American Church members to her home until her death in 2005, just before her 101st birthday.

Citi analysts forecast 19% earnings growth for the healthcare sector in 2025, up from 4% this year. The analysts point to the stocks' right-sized valuations and a potential improvement in fundamentals. The sector has lagged the S&P 500's rally this year, up just 1%, while the index has surged 26%. After a tough year marked by policy uncertainty and lagging fundamentals, healthcare stocks are set to change course in 2025, Citi says. The firm points to better valuations for the sector, offering an attractive entry point after months of outsize valuations. "What a difference a year makes. This past year's relative underperformance and flattish absolute return has gradually alleviated our valuation concerns," the analysts said in a Monday note. The sector has lagged the overall market's rally this year, up just 1.1%, while the S&P 500 has surged 26.2% so far. The analysts also point to subpar underlying fundamentals, which they say could reach a bottom soon. "This has been our most persistent Underweight during 2024. However, valuations have right sized and fundamentals appear closer to an inflection," the analysts said. Overall, they see the healthcare sector generating 19% earnings growth in 2025, compared to an expected 4% this year. The analysts' call comes after a tough year for the industry amid significant policy uncertainty, particularly after president-elect Donald Trump's appointment of Robert F. Kennedy Jr. to head the Department of Health and Human Services. Kennedy has been a vocal skeptic of vaccines. In the days after his nomination last month, vaccine makers like Moderna , Pfizer , Novavax, and GSK tumbled. In the time since, though, some analysts have said the reaction is overblown, particularly for weight-loss drugmakers like Wegovy, and Ozempic maker Novo Nordisk and Zepbound maker Eli Lilly. The selloffs "reflect more fear than real fundamental downside risk," BMO analysts argued in a note last month. They said Kennedy's role comes with limited ability to change policy impacting the pricing and availability of the drugs, meaning there's likely little risk to the shares of companies like Eli Lilly and Novo Nordisk. Citi's analysts seem to agree, forecasting returns of 64% for Eli Lilly, which carries the biggest weight in the sector at 12%. "Although policy controversy remains, we think this is largely priced in," the analysts wrote, adding that pharmaceutical and biotechnology stocks will likely lead the sector's outperformance in 2025. The analysts' call comes amid the firm's broader shift toward select defensive stocks. They say some cyclicals have rich valuations with little earnings growth seen in the near-future. "Some classic Defensive industry groups look intriguing. Certain Cyclicals may need to buy some time as valuations are rich while an earnings growth turn is not yet visible," the analysts wrote.

Al-Sisi, Frederiksen discuss strengthening Egypt-Denmark relationsMELBOURNE, Australia and INDIANAPOLIS , Dec. 30, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces that it has submitted its Biologics License Application (BLA) to the United States (U.S.) Food and Drug Administration (FDA) for TLX250-CDx (Zircaix®[1], 89 Zr- girentuximab) kidney cancer imaging[2]. TLX250-CDx is an investigational PET[3] drug product for the non-invasive diagnosis and characterisation of clear cell renal cell carcinoma (ccRCC), the most common and aggressive form of kidney cancer. If approved, TLX250-CDx will be the first and only targeted PET agent specifically for kidney cancer to be commercially available in the U.S., further building on Telix's successful urology imaging franchise. The FDA is expected to advise the PDUFA[4] goal date following the 60-day administrative review of the application. Kevin Richardson , Chief Executive Officer, Precision Medicine at Telix, stated, "We are pleased to be progressing the BLA for TLX250-CDx, which has been granted Breakthrough designation, and may therefore be eligible for priority review. Telix continues to target a full U.S. commercial launch in 2025 addressing a major unmet medical need for patients with suspected ccRCC." About TLX250-CDx TLX250-CDx (Zircaix® 1 ) is an investigational PET agent that is under development for the diagnosis and characterisation of ccRCC. Telix's pivotal Phase III ZIRCON trial (ClinicalTrials.gov ID: NCT03849118 ) evaluating TLX250-CDx in 300 patients, of whom 284 were evaluable, met all primary and secondary endpoints, including showing 86% sensitivity and 87% specificity and a 93% positive-predictive value for ccRCC across three independent radiology readers[5]. Telix believes this demonstrated the ability of TLX250-CDx to reliably detect the clear cell phenotype and provide an accurate, non-invasive method for diagnosing and characterising ccRCC. Confidence intervals exceeded expectations amongst all three readers, showing evidence of high accuracy and consistency of interpretation. About Telix Pharmaceuticals Limited Telix is a biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic radiopharmaceuticals and associated medical technologies. Telix is headquartered in Melbourne, Australia , with international operations in the United States , Europe ( Belgium and Switzerland ), and Japan . Telix is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX) and the Nasdaq Global Select Market (Nasdaq: TLX). Telix's lead imaging product, gallium-68 ( 68 Ga) gozetotide injection (also known as 68 Ga PSMA-11 and marketed under the brand name Illuccix®), has been approved by the U.S. Food and Drug Administration (FDA)[6], by the Australian Therapeutic Goods Administration (TGA) [7], and by Health Canada [8] . No other Telix product has received a marketing authorisation in any jurisdiction. Visit www.telixpharma.com for further information about Telix, including details of the latest share price, announcements made to the ASX, investor and analyst presentations, news releases, event details and other publications that may be of interest. You can also follow Telix on X and LinkedIn . Telix Investor Relations Ms. Kyahn Williamson Telix Pharmaceuticals Limited SVP Investor Relations and Corporate Communications Email: kyahn.williamson@telixpharma.com This announcement has been authorised for release by the Telix Pharmaceuticals Limited Disclosure Committee on behalf of the Board. Legal Notices You should read this announcement together with our risk factors, as disclosed in our most recently filed reports with the Australian Securities Exchange (ASX), U.S. Securities and Exchange Commission (SEC), including our registration statement on Form 20-F filed with the SEC, or on our website. The information contained in this announcement is not intended to be an offer for subscription, invitation or recommendation with respect to securities of Telix Pharmaceuticals Limited (Telix) in any jurisdiction, including the United States . The information and opinions contained in this announcement are subject to change without notification. To the maximum extent permitted by law, Telix disclaims any obligation or undertaking to update or revise any information or opinions contained in this announcement, including any forward-looking statements (as referred to below), whether as a result of new information, future developments, a change in expectations or assumptions, or otherwise. No representation or warranty, express or implied, is made in relation to the accuracy or completeness of the information contained or opinions expressed in the course of this announcement. This announcement may contain forward-looking statements, including within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, that relate to anticipated future events, financial performance, plans, strategies or business developments. Forward-looking statements can generally be identified by the use of words such as "may", "expect", "intend", "plan", "estimate", "anticipate", "believe", "outlook", "forecast" and "guidance", or the negative of these words or other similar terms or expressions. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements are based on Telix's good-faith assumptions as to the financial, market, regulatory and other risks and considerations that exist and affect Telix's business and operations in the future and there can be no assurance that any of the assumptions will prove to be correct. In the context of Telix's business, forward-looking statements may include, but are not limited to, statements about: the initiation, timing, progress and results of Telix's preclinical and clinical trials, and Telix's research and development programs; Telix's ability to advance product candidates into, enrol and successfully complete, clinical studies, including multi-national clinical trials; the timing or likelihood of regulatory filings and approvals for Telix's product candidates, manufacturing activities and product marketing activities; Telix's sales, marketing and distribution and manufacturing capabilities and strategies; the commercialisation of Telix's product candidates, if or when they have been approved; Telix's ability to obtain an adequate supply of raw materials at reasonable costs for its products and product candidates; estimates of Telix's expenses, future revenues and capital requirements; Telix's financial performance; developments relating to Telix's competitors and industry; and the pricing and reimbursement of Telix's product candidates, if and after they have been approved. Telix's actual results, performance or achievements may be materially different from those which may be expressed or implied by such statements, and the differences may be adverse. Accordingly, you should not place undue reliance on these forward-looking statements. ©2024 Telix Pharmaceuticals Limited. The Telix Pharmaceuticals®, Illuccix® and Zircaix® 1 names and logos are trademarks of Telix Pharmaceuticals Limited and its affiliates – all rights reserved.

None